Neurofibromatosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

Selumetinib Paediatric NF1 Japan Phase 1 Study
Condition:   Neurofibromatosis Type 1 and Inoperable and Symptomatic Plexiform Neurofibroma Intervention:   Drug: Selumetinib Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 31, 2020 Category: Research Source Type: clinical trials

Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1
Condition:   Neurofibromatosis 1 Interventions:   Drug: N-Acetyl cysteine;   Other: Placebo Sponsors:   Children's Hospital Medical Center, Cincinnati;   United States Department of Defense Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2020 Category: Research Source Type: clinical trials

Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1
Condition:   Neurofibromatosis 1 Interventions:   Drug: N-acetylcysteine (NAC);   Other: Placebo Sponsor:   Children's Hospital Medical Center, Cincinnati Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2020 Category: Research Source Type: clinical trials

Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1
Condition:   Neurofibromatosis 1 Interventions:   Drug: N-Acetyl cysteine;   Other: Placebo Sponsors:   Children's Hospital Medical Center, Cincinnati;   United States Department of Defense Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2020 Category: Research Source Type: clinical trials

Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1
Condition:   Neurofibromatosis 1 Interventions:   Drug: N-acetylcysteine (NAC);   Other: Placebo Sponsor:   Children's Hospital Medical Center, Cincinnati Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2020 Category: Research Source Type: clinical trials

Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1
Condition:   Neurofibromatosis 1 Interventions:   Drug: N-Acetyl cysteine;   Other: Placebo Sponsors:   Children's Hospital Medical Center, Cincinnati;   United States Department of Defense Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2020 Category: Research Source Type: clinical trials